NCT07019922Phase 3Recruiting

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

Study sponsor: Praxis Precision Medicines

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-12Estimated
Enrollment · participants40Estimated
Source updated2026-08-03Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Jun 2026. After: Dec 2026.

Check registry source

· 1 field changed

Planned enrollment decreased by 10 participants

Before: 50 participants (planned). After: 40 participants (planned).

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview